Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why
Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection
The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its tissue of origin from a single blood sample.
Market Trading Guide: Suven Life Sciences among 2 stock recommendations for Friday - The Economic Times
Market Trading Guide: Suven Life Sciences among 2 stock recommendations for FridayThe Economic Times
Market Trading Guide: Suven Life Sciences among 2 stock recommendations for Friday
Indian markets advanced on easing crude prices and dovish Fed commentary, boosting risk appetite. Analysts recommend buying NDR Auto and Suven Life Sciences after bullish breakouts, while investors await US jobs data, the India–Japan summit and Q1FY27 earnings.
Godavari Biorefineries shares rises 10% on Japanese patent for cancer treatment invention
Godavari Biorefineries said the patented invention relates to the use of 5-Hydroxy-1,4-Naphthalenedione in the treatment of cancer and strengthens its intellectual property portfolio in the healthcare and life sciences space.
Anupam Rasayan becomes world's first to make ETFA using flow chemistry
Anupam Rasayan India Ltd has achieved a global first by commercialising Ethyl trifluoroacetate production using its unique continuous flow chemistry technology. This advanced method offers enhanced safety and efficiency over traditional batch processes. ETFA is a vital component for pharmaceuticals and life sciences.
Multibagger Anupam Rasayan stock to be in focus on Friday on ETFA manufacturing milestone
Anupam Rasayan India announces commercialization of ETFA production via a proprietary continuous flow chemistry platform, making it the first globally to do so. The market potential for ETFA is $500-600 million, crucial for fluorinated compounds in pharmaceuticals and life sciences.
Analysts project up to 17% upside in healthcare stocks trading at new highs
Apollo Hospitals, Aster DM Healthcare, Sai Life Sciences have rallied up to 27% thus far in FY27; technical analysts remain bullish on these stocks given the favourable chart set-up.
Jagran Prakashan Ltd leads losers in 'B' group
Suven Life Sciences Ltd, Ravindra Energy Ltd, Sunflag Iron & Steel Company Ltd and Exicom Tele-Systems Ltd are among the other losers in the BSE's 'B' group today, 05 June 2026.
Sunil Singhania’s Abakkus Portfolio: 6 stocks rally up to 75% in CY26; 5 new buys added in Q4
Sunil Singhania’s Abakkus Asset Manager portfolio rose 6% to Rs 2,742 crore in March 2026 quarter, with mixed CY26 performance showing strong gains in Avalon Technologies and Suven Life Sciences amid several notable stock declines.
Gainers & Losers: Cochin Shipyard, Suven Life Sciences among 6 top movers on Monday
Alivus Life Sciences Q4 PAT climbs 15% YoY to Rs 163 cr
Alivus Life Sciences reported 14.66% jump in standalone net profit to Rs 162.66 crore on 6.09% increase in revenue from operations to Rs 689.11 crore in Q4 FY26 over Q4 FY25.